Initial Antihypertensive Regimen for BP 160/100
For stage 2 hypertension (BP 160/100 mm Hg), start with a single-pill fixed-dose combination of 2 first-line antihypertensive agents from different classes 1, 2.
Recommended Initial Combination Therapy
The 2025 AHA/ACC guidelines explicitly prioritize combination therapy for stage 2 hypertension because:
- Single-pill combinations (SPCs) improve medication adherence compared to taking 2 separate pills 1
- Faster BP control is achieved, reducing the time patients remain at high cardiovascular risk 1
- Lower cardiovascular events and all-cause mortality in observational studies compared to multiple separate pills 1
Preferred Drug Class Combinations
For non-Black patients:
- ACE inhibitor + thiazide diuretic, OR
- ARB + thiazide diuretic, OR
- ACE inhibitor + calcium channel blocker, OR
- ARB + calcium channel blocker 1, 3
For Black patients (including those with diabetes):
- Calcium channel blocker + thiazide diuretic 3
The thiazide diuretic component should preferably be chlortalidone (strongest evidence base) or hydrochlorothiazide if chlortalidone unavailable 4.
Critical Contraindications to Avoid
Never combine:
- ACE inhibitor + ARB (increases CVD, kidney disease, and hyperkalemia risk) 1
- ACE inhibitor or ARB + aliskiren (direct renin inhibitor) 1
- Two drugs from the same class (e.g., 2 different ACE inhibitors) 1
Exception: Thiazide + potassium-sparing diuretics or thiazide + loop diuretics can be combined 1
When to Consider Monotherapy Instead
The stepped-care approach (starting with a single agent) remains reasonable for 1:
- Older adults at risk for hypotension or orthostatic hypotension
- Patients with history of medication-related hypotension
- Patients with multiple prior drug-associated side effects
- Frail elderly patients requiring careful BP monitoring
However, recognize that most patients with stage 2 hypertension require at least 2 drug classes to achieve BP control 1.
Target Blood Pressure Goals
- General population <60 years: <140/90 mm Hg 3
- Age ≥60 years: <150/90 mm Hg 3
- Diabetes or chronic kidney disease: <130/80 mm Hg 2, 5
Implementation Considerations
Dosing frequency: Prescribe once-daily formulations whenever possible to improve adherence 1
Follow-up timing: SPCs allow for longer intervals between dose adjustments compared to stepped-care, as you're starting with adequate therapy upfront 1
Cost-effectiveness: SPCs are generally cost-effective alternatives to multiple-pill regimens, though separate agents may occasionally be more efficient when specific dose combinations aren't available as SPCs 1
Common Pitfall
The most critical error is delaying adequate treatment by starting monotherapy in stage 2 hypertension. At BP 160/100, the patient is ≥20/10 mm Hg above goal, which is the explicit threshold where combination therapy is indicated 1, 2, 5. This delay prolongs exposure to dangerously elevated BP and increases cardiovascular risk.